Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
Pubmed

ZFP57 dictates allelic expression switch of target imprinted genes.

ZDBF2 KCNQ1

1.04e-05257233500348
InteractionKCNE4 interactions

SLC30A3 KCNQ1

7.62e-053972int:KCNE4
GeneFamilySolute carriers

SLC38A10 SLC30A3

6.74e-0339562752
CoexpressionLIN_MELANOMA_COPY_NUMBER_UP

PRUNE1 SLC38A10

1.55e-047272M346
CoexpressionGSE7219_UNSTIM_VS_LPS_AND_ANTI_CD40_STIM_NIK_NFKB2_KO_DC_UP

PRUNE1 ARHGAP5

9.42e-0417872M383
CoexpressionGSE1460_DP_THYMOCYTE_VS_THYMIC_STROMAL_CELL_UP

PRUNE1 KCNQ1

1.13e-0319572M3467
CoexpressionGSE14769_UNSTIM_VS_40MIN_LPS_BMDM_UP

ZDBF2 ZNF276

1.17e-0319972M3493
CoexpressionGSE11924_TH2_VS_TH17_CD4_TCELL_UP

SLC38A10 ARHGAP5

1.17e-0319972M3164
CoexpressionGSE29949_MICROGLIA_VS_DC_BRAIN_DN

PRUNE1 KCNQ1

1.17e-0319972M8405
CoexpressionGSE17721_CTRL_VS_CPG_12H_BMDC_DN

SLC30A3 ZNF276

1.17e-0319972M3770
CoexpressionGSE17721_PAM3CSK4_VS_CPG_0.5H_BMDC_DN

ZNF276 ARHGAP5

1.19e-0320072M3851
CoexpressionGSE15324_NAIVE_VS_ACTIVATED_ELF4_KO_CD8_TCELL_DN

SLC30A3 ARHGAP5

1.19e-0320072M3527
CoexpressionGSE15324_NAIVE_VS_ACTIVATED_CD8_TCELL_DN

PRUNE1 SLC30A3

1.19e-0320072M3525
CoexpressionGSE9037_WT_VS_IRAK4_KO_LPS_1H_STIM_BMDM_DN

ZDBF2 SLC38A10

1.19e-0320072M5816
CoexpressionGSE21670_UNTREATED_VS_TGFB_TREATED_CD4_TCELL_UP

SLC30A3 KCNQ1

1.19e-0320072M7471
CoexpressionGSE43955_10H_VS_60H_ACT_CD4_TCELL_WITH_TGFB_IL6_DN

PRUNE1 KCNQ1

1.19e-0320072M9687
CoexpressionGSE25123_WT_VS_PPARG_KO_MACROPHAGE_ROSIGLITAZONE_STIM_UP

KCNQ1 ARHGAP5

1.19e-0320072M7978
CoexpressionGSE37301_MULTIPOTENT_PROGENITOR_VS_CD4_TCELL_DN

PRUNE1 ZNF276

1.19e-0320072M8847
CoexpressionGSE16450_CTRL_VS_IFNA_12H_STIM_MATURE_NEURON_CELL_LINE_UP

PRUNE1 KCNQ1

1.19e-0320072M7411
CoexpressionGSE27434_WT_VS_DNMT1_KO_TREG_UP

SLC38A10 ZNF276

1.19e-0320072M9620
ToppCell10x3'2.3-week_14-16-Lymphocytic_NK-T_NK-NK_progenitor|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

ZDBF2 ZNF276

2.81e-0416672b041010038a570ad929812f35514cb54e4f68f66
ToppCellLPS-antiTNF-Epithelial_alveolar-Mes-like-AT2_Progenitor|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

PRUNE1 ZNF276

2.88e-04168729e7b4b9b977e90e083f5164013e79df8bc2d492e
ToppCelldroplet-Lung-30m-Hematologic-myeloid-myeloid_dendritic_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

ZDBF2 ARHGAP5

2.91e-0416972b2d53159e344fad6fcdc485d5b8f6cf1bf094b1f
ToppCelldroplet-Pancreas-Endocrine-18m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ZDBF2 ARHGAP5

3.71e-0419172fd01a206763dfb6d52cca67123571936b4a8e1a0
ToppCelldroplet-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SLC38A10 ARHGAP5

3.75e-04192721304e69c92cef3bd8c82e3c035a7562f5440139a
ToppCellfacs-Brain_Non-Myeloid-Cortex-3m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ZDBF2 SLC30A3

3.79e-0419372461919ab422bc9d1fcff7a3a4757c75239041d7e
ToppCellfacs-Brain_Non-Myeloid-Cortex-3m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ZDBF2 SLC30A3

3.79e-04193720dd810ad900d3e586551622b2c1de39d76fd6a7f
ToppCelldroplet-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SLC38A10 ARHGAP5

3.83e-041947292b39a935e8c577eb1123d706d168fa13cf3344c
ToppCellfacs-Brain_Non-Myeloid-Cortex-3m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ZDBF2 SLC30A3

3.87e-0419572ffbab350e67d9c4b66c0ab84550daec8b8139a27
ToppCellT_cells-Treg_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis

ZDBF2 ARHGAP5

3.95e-0419772ec9398ae3577f61d6b1e6aba50ef4261aaaa7610
ToppCellSigmoid-T_cell-Activated_CD4_T|T_cell / Region, Cell class and subclass

KCNQ1 ARHGAP5

4.07e-04200729c21e6b8d4f8e526950adacf9cc45a5e86d81c1f
DrugAntigens, Polyomavirus Transforming

PRUNE1 SLC38A10 ARHGAP5

8.06e-0466873ctd:D000952
DrugVerteporfin [129497-78-5]; Down 200; 2.8uM; MCF7; HT_HG-U133A

SLC38A10 ZNF276

9.46e-04155726817_DN
DrugParthenolide [20554-84-1]; Up 200; 16.2uM; MCF7; HT_HG-U133A

PRUNE1 SLC30A3

1.08e-03166722885_UP
DrugVanadium

SLC30A3 KCNQ1

1.18e-0317372ctd:D014639
DrugNimodipine [66085-59-4]; Up 200; 9.6uM; HL60; HT_HG-U133A

SLC30A3 KCNQ1

1.34e-03185723103_UP
DrugTrichostatin A, Streptomyces sp.; Up 200; 0.1uM; HL60; HT_HG-U133A

PRUNE1 ARHGAP5

1.40e-03189722672_UP
Drugradicicol, diheterospora chlamydosporia; Up 200; 0.1uM; MCF7; HT_HG-U133A

SLC30A3 ARHGAP5

1.42e-03190725579_UP
Drug0175029-0000 [211245-78-2]; Up 200; 1uM; PC3; HT_HG-U133A

PRUNE1 ZNF276

1.44e-03192727392_UP
DrugOzagrel hydrochloride [78712-43-3]; Up 200; 15.2uM; HL60; HT_HG-U133A

PRUNE1 ZNF276

1.49e-03195722942_UP
Drugradicicol; Up 200; 0.1uM; PC3; HG-U133A

PRUNE1 ARHGAP5

1.49e-0319572449_UP
DrugAmoxapine [14028-44-5]; Down 200; 12.8uM; PC3; HT_HG-U133A

PRUNE1 ZNF276

1.49e-03195726650_DN
Drugradicicol; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA

SLC38A10 ZNF276

1.49e-0319572953_DN
DrugChrysin [480-40-0]; Up 200; 15.8uM; HL60; HT_HG-U133A

ZNF276 KCNQ1

1.50e-03196723106_UP
DrugMoxonidine [75438-57-2]; Down 200; 16.6uM; HL60; HT_HG-U133A

PRUNE1 SLC38A10

1.50e-03196722923_DN
DrugLetrozole [112809-51-5]; Up 200; 14uM; MCF7; HT_HG-U133A

PRUNE1 SLC30A3

1.50e-03196724824_UP
DrugPNU-0293363 [326823-19-2]; Down 200; 10uM; PC3; HT_HG-U133A

PRUNE1 SLC38A10

1.50e-03196726563_DN
DrugColistin sulfate [1264-72-8]; Up 200; 3uM; MCF7; HT_HG-U133A

PRUNE1 SLC30A3

1.52e-03197724796_UP
DrugGlycopyrrolate [596-51-0]; Up 200; 10uM; HL60; HT_HG-U133A

ZNF276 KCNQ1

1.52e-03197722565_UP
DrugMinaprine dihydrochloride [25953-17-7]; Down 200; 10.8uM; MCF7; HT_HG-U133A

PRUNE1 ZNF276

1.52e-03197724814_DN
DrugIoversol [87771-40-2]; Up 200; 5uM; HL60; HT_HG-U133A

ZNF276 KCNQ1

1.52e-03197723026_UP
DrugSulfaphenazole [526-08-9]; Down 200; 12.8uM; MCF7; HT_HG-U133A

PRUNE1 ZNF276

1.52e-03197725507_DN
DrugTolmetin sodium salt dihydrate [64490-92-2]; Up 200; 12.6uM; PC3; HT_HG-U133A

SLC30A3 KCNQ1

1.52e-03197724088_UP
DrugSeneciphylline [480-81-9]; Up 200; 12uM; HL60; HT_HG-U133A

ZNF276 KCNQ1

1.52e-03197722140_UP
DrugSulfamethizole [144-82-1]; Up 200; 14.8uM; HL60; HT_HG-U133A

ZNF276 KCNQ1

1.54e-03198722536_UP
DrugDemecarium bromide [56-94-0]; Down 200; 5.6uM; MCF7; HT_HG-U133A

PRUNE1 ZNF276

1.54e-03198726269_DN
Drug0173570-0000 [211245-44-2]; Up 200; 1uM; PC3; HT_HG-U133A

PRUNE1 ZNF276

1.54e-03198727391_UP
DrugUrosiol [128-13-2]; Up 200; 10.2uM; MCF7; HT_HG-U133A

SLC30A3 ZNF276

1.54e-03198726484_UP
DrugCalciferol [50-14-6]; Up 200; 10uM; MCF7; HT_HG-U133A

PRUNE1 ZNF276

1.54e-03198725346_UP
DrugFlucloxacillin sodium [1847-24-1]; Up 200; 8.4uM; HL60; HT_HG-U133A

ZNF276 KCNQ1

1.54e-03198723128_UP
DrugOndansetron Hydrochloride [103639-04-9]; Down 200; 12.2uM; HL60; HT_HG-U133A

ZNF276 KCNQ1

1.54e-03198726153_DN
DrugBephenium hydroxynaphthoate [3818-50-6]; Up 200; 9uM; HL60; HT_HG-U133A

ZNF276 KCNQ1

1.55e-03199723089_UP
DrugIsradipine [75695-93-1]; Up 200; 10.8uM; HL60; HT_HG-U133A

KCNQ1 ARHGAP5

1.55e-03199723129_UP
DrugZomepirac sodium salt [64092-48-4]; Down 200; 12.8uM; HL60; HT_HG-U133A

ZNF276 KCNQ1

1.55e-03199722713_DN
DrugDiethylstilbestrol [56-53-1]; Up 200; 15uM; HL60; HT_HG-U133A

ZNF276 KCNQ1

1.55e-03199722567_UP
Drugrapamycin, Streptomyces hygroscepicus; Up 200; 0.1uM; MCF7; HT_HG-U133A

SLC30A3 KCNQ1

1.55e-03199725927_UP
DrugDisopyramide [3737-09-5]; Up 200; 11.8uM; MCF7; HT_HG-U133A

SLC38A10 SLC30A3

1.55e-03199727439_UP
Drug2-propylpentanoic acid; Up 200; 50uM; MCF7; HT_HG-U133A

PRUNE1 KCNQ1

1.55e-03199726941_UP
DrugFluorocurarine chloride [22273-09-2]; Down 200; 11.6uM; MCF7; HT_HG-U133A

PRUNE1 ARHGAP5

1.55e-03199726219_DN
DrugMometasone furoate [83919-23-7]; Down 200; 7.6uM; MCF7; HT_HG-U133A

PRUNE1 ZNF276

1.55e-03199725541_DN
DrugIodipamide [606-17-7]; Up 200; 3.6uM; HL60; HT_HG-U133A

ZNF276 KCNQ1

1.57e-03200723111_UP
Diseasetrauma exposure measurement

PRUNE1 KCNQ1

6.96e-0417272EFO_0010703
Diseaseuric acid measurement

ZNF276 KCNQ1

8.36e-0361072EFO_0004761
Diseaseurate measurement

SLC30A3 KCNQ1

1.74e-0289572EFO_0004531
DiseaseC-reactive protein measurement

SLC30A3 ZNF276

3.06e-02120672EFO_0004458

Protein segments in the cluster

PeptideGeneStartEntry
DHRPIEPKHCPPCHV

PRUNE1

126

Q86TP1
PHITCDPPEERRLDH

KCNQ1

441

P51787
AHTRVHVECPPAHVP

CRIPAK

66

Q8N1N5
VGEAHRHEPPVPHDK

SLC38A10

491

Q9HBR0
NCHDHERNHKVPPPI

ARHGAP5

1026

Q13017
KEHHEEVRERPCPHP

ZNF276

456

Q8N554
VALDKPCHRHPPAER

ZDBF2

1911

Q9HCK1
KPVEMPFHHCHRDPL

SLC30A3

46

Q99726
VPKRDPEHSREESHP

UNQ6494/PRO21346

166

Q6UXR6